Collaboration is key to our success. Explore what we’re saying, what we’re sharing and what we’re thinking.
Does helping to make life better for millions of people motivate you? If you want to make your mark in a growing healthcare company, find out about...
We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
The longer a wound remains undisturbed, the better chance it has of healing without complication.
Molnlycke Advantage is a customised learning hub for wound care professionals.
Read news and updates about our company.
Mölnlycke News
Mepilex Ag in the management of partial-thickness burns: A review of the clinical evidence
Pawlak, U., Davies, P., Wounds International 2022
Mölnlycke announces price increases
Despite the fact that Mölnlycke has introduced a number of measures, the current global macro-economic challenges are now forcing us to raise prices....
Mölnlycke publishes 2021 Annual and Sustainability report
Mölnlycke’s integrated Annual and Sustainability Report is now available for download, outlining the company’s results and performance in 2021.
Mölnlycke have been awarded a silver medal for sustainability
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a silver medal for our focus on...
Regarding the tragic events in Ukraine
We are deeply concerned about the current security situation in Europe and fully support the condemnation of Russia's invasion of Ukraine. While Mölnlyc...
Mölnlycke to relocate HQ to GoCo Health Innovation City
In late 2024 Mölnlycke will relocate to brand new headquarters in GoCo Health Innovation City in Mölndal. The new headquarters will have a total area of...
Mölnlycke to advance wound care with new technology
We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home. Now we are gearing up for a...
Granulox® wins Prix Galien
Mölnlycke’s haemoglobin spray Granulox ® has been awarded the prestigious Prix Galien for best new medical device in Belgium and Luxembourg.
New structure sets Mölnlycke up for the future
Mölnlycke now moves to a new structure based on business areas, driven from a customer centric perspective with an end-to-end responsibility. At the sam...
Barry McBride to take on the position as interim CEO
Gothenburg – 24 July 2020 Barry McBride, EVP Gloves, Antiseptics and Global R&D, will take on the role as interim CEO as of 1 August and until the new...
Mölnlycke acquires German wound care company SastoMed GmbH
The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...
Creating opportunities at AZ BioVenture Hub
Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
